ZYME
Zymeworks Inc.
Key Financials
Operating Income
$-92549000
↑ 32.5%
Revenue
$106.0M
↑ 38.9%
Net Income
$-81130000
↑ 33.9%
EPS (Diluted)
$-1.08
↑ 33.3%
Total Assets
$346.5M
↓ 25.2%
Total Liabilities
$78.0M
↓ 37.2%
Cash & Equivalents
$41.2M
↓ 37.7%
Shareholders' Equity
$268.5M
↓ 20.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZYME |
| Company Name | Zymeworks Inc. |
| CIK | 1937653 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 302-274-8744 |